GSK-A1 - Moligand™,≥98% , CAS No.1416334-69-4
In stock
SKU
G651371
More Information
| CAS | 1416334-69-4 |
|---|---|
| Synonyms | 5-(2-Amino-1-(4-morpholinophenyl)-1H-benzimidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide | 5-(2-Amino-1-(4-morpholinophenyl)-1H-benzo[d]imidazol-6-yl)-N-(2-fluorophenyl)-2-methoxypyridine-3-sulfonamide | 5-[2-Amino-1-[4-(4-morpholinyl)ph |
| Specifications & Purity | Moligand™,≥98% |
| Storage | Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| Product Description | |
| Bioactivity | GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA (PI4KIIIα) inhibitor with a pIC50 of 8.5-9.8. GSK-A1 inhibits PtdIns(4,5)P2 resynthesis with an IC50 of about 3 nM. GSK-A1 potently decreases the levels of PtdIns(4)P with a negligible effect on PtdIns(4,5)P2. GSK-A1 has the potential for anti-hepatitis C virus (HCV) research. |
| PubChem CID | 71116366 |
Reviews
Customer Reviews
Remind me later